Major change to global asthma management recommendations
New global recommendations on the management and treatment of asthma purport that all adults and adolescents with asthma should receive either symptom-driven (in mild asthma) or daily low dose inhaled corticosteroid (ICS) in combination with formoterol, a long-acting beta2-agonist (LABA), as the optimal reliever...
Read more